Evidence map›Paper›PMID 26932929›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2016

Divergence of mechanistic pathways mediating cardiovascular aging and developmental programming of cardiovascular disease.

Beth J Allison, Joepe J Kaandorp, Andrew D Kane, Emily J Camm, Ciara Lusby, Christine M Cross, Rhianon Nevin-Dolan, Avnesh S Thakor, Jan B Derks, Jane L Tarry-Adkins and 2 more

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
21.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Observational
  3. Review
  4. Review
  5. Review
  6. Article
  7. Antioxidants: powering the fight against fetal hypoxia.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Beth J AllisonDepartment of Physiology Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom;
Joepe J KaandorpPerinatology, University Medical Center, Utrecht, The Netherlands; and.
Andrew D KaneDepartment of Physiology Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom;
Emily J CammDepartment of Physiology Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom;
Ciara LusbyDepartment of Physiology Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom;
Christine M CrossDepartment of Physiology Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom;
Rhianon Nevin-DolanDepartment of Physiology Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom;
Avnesh S ThakorDepartment of Physiology Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom;
Jan B DerksPerinatology, University Medical Center, Utrecht, The Netherlands; and.
Jane L Tarry-AdkinsMetabolic Research Laboratories and Medical Reseach Council (MRC) Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, United Kingdom.
Susan E OzanneMetabolic Research Laboratories and Medical Reseach Council (MRC) Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, United Kingdom.
Dino A GiussaniDepartment of Physiology Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom; dag26@camac.uk.
University of Cambridge · GBUtrecht University · NLAddenbrooke's Hospital · GBWellcome Trust · GB

Funding

Biotechnology and Biological Sciences Research Council BB/E002668/1British Heart Foundation FS/09/029/27902British Heart Foundation FS/12/74/29778British Heart Foundation PG/10/99/28656British Heart Foundation PG/14/5/30547British Heart Foundation RG/06/006/22028British Heart Foundation RG/11/16/29260Medical Research Council MC_UU_12012/4Medical Research Council MC_UU_12012/5Medical Research Council MRC_MC_UU_12012/4Wellcome Trust
6 · The paper itself

Abstract

Aging and developmental programming are both associated with oxidative stress and endothelial dysfunction, suggesting common mechanistic origins. However, their interrelationship has been little explored. In a rodent model of programmed cardiovascular dysfunction we determined endothelial function and vascular telomere length in young (4 mo) and aged (15 mo) adult offspring of normoxic or hypoxic pregnancy with or without maternal antioxidant treatment. We show loss of endothelial function [maximal arterial relaxation to acetylcholine (71 ± 3 vs. 55 ± 3%) and increased vascular short telomere abundance (4.2-1.3 kb) 43.0 ± 1.5 vs. 55.1 ± 3.8%) in aged vs. young offspring of normoxic pregnancy (P < 0.05). Hypoxic pregnancy in young offspring accelerated endothelial dysfunction (maximal arterial relaxation to acetylcholine: 42 ± 1%, P < 0.05) but this was dissociated from increased vascular short telomere length abundance. Maternal allopurinol rescued maximal arterial relaxation to acetylcholine in aged offspring of normoxic or hypoxic pregnancy but not in young offspring of hypoxic pregnancy. Aged offspring of hypoxic allopurinol pregnancy compared with aged offspring of untreated hypoxic pregnancy had lower levels of short telomeres (vascular short telomere length abundance 35.1 ± 2.5 vs. 48.2 ± 2.6%) and of plasma proinflammatory chemokine (24.6 ± 2.8 vs. 36.8 ± 5.5 pg/ml, P < 0.05). These data provide evidence for divergence of mechanistic pathways mediating cardiovascular aging and developmental programming of cardiovascular disease, and aging being decelerated by antioxidants even prior to birth.-Allison, B. J., Kaandorp, J. J., Kane, A. D., Camm, E. J., Lusby, C., Cross, C. M., Nevin-Dolan, R., Thakor, A. S., Derks, J. B., Tarry-Adkins, J. L., Ozanne, S. E., Giussani, D. A. Divergence of mechanistic pathways mediating cardiovascular aging and developmental programming of cardiovascular disease.

Indexed as

Cardiovascular Physiological PhenomenaAgingAllopurinolAnimalsAntimetabolitesBiomarkersCardiovascular DiseasesFemaleInflammationMaleOxidative StressPregnancyRatsAllopurinolAntimetabolitesBiomarkersallopurinolcell senescencefetal hypoxiaoxidative stressxanthine oxidase

Identifiers

PMID26932929
PMCPMC5036970
OpenAlexW2295784524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.